Consolidated Statements of Cash Flows $ in Thousands	12 Months Ended
	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Cash flows from operating activities
Net loss	$ (397,082)	$ (355,847)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	64,807	71,442
Amortization of operating lease right-of-use assets	3,032	2,588
Non-cash interest expense	4,870	1,929
Loss (gain) on digital assets, net	4,117	0
Loss (gain) on disposal of property and equipment, net	2,459	1,667
Asset impairment	137,435	1,847
Goodwill impairment	4,450	0
Stock-based compensation	3,150	8,382
Reserve on inventory	17,829	476
Credit loss expense	4,294	0
Accrued interest on short-term note receivable	(189)	0
H.S.L. SRL. settlement adjustment	(295)	0
Settlement on accrued research and development expenses	0	(14,935)
Change in fair value of notes payable, warrant liabilities, and derivative liabilities	(49,093)	15,058
Change in fair value of related party notes payable, warrant liabilities, and derivative liabilities	1,627	(253)
Other	55	963
Changes in operating assets and liabilities
Accounts receivables	(257)	0
Inventory	706	6,267
Deposits	(376)	(706)
Accounts payable	(15,843)	(8,804)
Operating lease liabilities	(3,572)	0
Financing lease liabilities	0	2,876
Other current and non-current assets	(1,088)	(3,200)
Net cash used in operating activities	(107,576)	(70,186)
Cash flows from investing activities
Acquisition of AIXC, net of cash acquired	(1,121)	0
Proceeds from sale of equipment	32	198
Purchase of digital assets	(27,000)	0
Sale of digital assets	12,632	0
Payments for property and equipment	(7,644)	(7,580)
Purchase of short-term note receivable	(100)	0
Additions to intangible assets	(256)	0
Net cash used in investing activities	(23,457)	(7,382)
Cash flows from financing activities
Proceeds from AIXC follow-on capital contribution, net of issuance costs	9,899	0
Payments of notes payable and other financing obligations	(4,932)	(428)
Capital contributions	0	250
Proceeds from other financial obligations	5,081	11,812
Proceeds from exercise of warrants	1,441	0
Net cash provided by financing activities	161,402	80,733
Effect of exchange rate changes on cash and restricted cash	(2,589)	(16)
Net increase in cash and restricted cash	27,780	3,149
Cash and restricted cash, beginning of period	7,174	4,025
Cash and restricted cash, end of period	34,954	7,174
Cash and restricted cash
Cash and cash equivalents	34,927	7,144
Restricted cash	27	30
Cash, cash equivalents, restricted cash, and restricted cash equivalents	34,954	7,174
Supplemental disclosure of cash flow information
Cash paid for interest	6,180	4,865
Cash paid for income taxes	14	0
Supplemental disclosure of noncash investing and financing activities
Reclass of warrants from liability to equity	7,134	0
Conversion of notes payable and accrued interest into Class A Common Stock	84,310	67,113
Issuance of warrants and related party warrants with the SPA Portfolio Notes	49,364	34,440
Settlement of vendor liability in Class A Common Stock	1,833	0
Non-cash warrant exercise activity and fair value reclassifications to equity	20,251	0
Additions of property and equipment included in accounts payable and accrued expenses	40,002	44,540
Shares withheld for RSU tax obligations	0	10
Purchase of Class A Common Stock under the Salary Deduction and Stock Purchase Agreements	0	102
De-recognition of right-of-use assets and lease liabilities due to lease modifications	0	3,394
Cancellation of warrants	27,407	0
Obtaining right-of-use asset in exchange for operating lease liabilities	6,206	30
Supplemental disclosure of noncash operating activities
Settlement of Palantir dispute with issuance of Class A Common Stock	0	4,800
Nonrelated Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	100,524	161,725
Changes in operating assets and liabilities
Accrued expenses and other current liabilities	4,069	16,907
Cash flows from financing activities
Payments of notes payable issuance costs	(2,540)	(2,087)
Proceeds from notes payable, net of original issuance discount	151,739	68,111
Related Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	5,128	14,295
Changes in operating assets and liabilities
Accrued expenses and other current liabilities	1,667	(1,573)
Related party accrued interest expense	0	8,710
Cash flows from financing activities
Payments of notes payable issuance costs	(4,017)	0
Proceeds from notes payable, net of original issuance discount	$ 4,731	$ 3,075